Derived from nitropyridinium, its preparation and use against tuberculosis and other infectious diseases.

OA22303AActive Publication Date: 2026-08-31FÉLIX HOUPHOUËT-BOIGNY UNIVERSITY FACULTY OF PHARMACEUTICAL & BIOLOGICAL SCIENCES FUND FOR SCIENCE TECHNOLOGY & INNOVATION (FONSTI)
0 Cites 0 Cited by

Patent Information

Application Number
OA1202500026
Authority / Receiving Office
OA · OA
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-11-12
Publication Date
2026-08-31
Estimated Expiration
2044-11-12
Patent Text Reader

Abstract

The present invention relates to nitropyridinium derivatives of general formula (1) active on sensitive and resistant strains of Mycobacterium tuberculosis and other species of Mycobacterium responsible for human or veterinary pathologies, and on Plasmodium falciparum, Staphylococcus aureus, Staphy / ococcus epidermis, Leishmania donovani, Candida albicans, Trypanosama brucei, Aspergillus fumigatus. The derivatives according to the invention are used in the treatment of sensitive and resistant forms of the following infectious diseases: tuberculosis, leishmaniasis, malaria and against certain bacterial infections with Staphylococcus aureus and Staphylococcus epidermis as well as against fungal infections with Candida albicans and Aspergillus fumigatus. The nitropyridinium derivatives according to the invention are obtained by nitration and / or substitution of a methyl group and / or an oxygen atom on a nitrogen heterocycle, nitrated or not.
Need to check novelty before this filing date? Find Prior Art